Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe study record area displays a 403 Forbidden message and a Home link, leaving the trial details unavailable.SummaryDifference0.5%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA 403 Forbidden page is now displayed, replacing the study details and navigation. Viewers can no longer access the study record from this page.SummaryDifference17%

- Check48 days agoChange DetectedFooter revision updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.0%

- Check69 days agoChange DetectedThe revision tag on the page changed from v3.6.4 to v3.6.5, signaling a newer release of the page or its underlying system. This is a metadata update and does not modify study content or user-visible features.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page now displays a new revision tag: v3.6.4, replacing v3.6.3. This is a minor UI/system update and does not alter study content or data.SummaryDifference0.0%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.